How Alex Azar could try to shake up drug prices through Medicare Part B

Any changes to Medicare Part B are likely to generate controversy — as they have in the past — but Alex Azar may seen an opportunity to rein in drug prices.

WASHINGTON — Alex Azar might have big plans to overhaul how Medicare pays for drugs.

At a congressional hearing at the end of November, the nominee to be secretary of Health and Human Services wondered aloud about how to modify a government health insurance program that helps tens of millions of Americans over the age of 65 pay for medicines. Such changes might impact the price of the drugs across the board.

Continue to STAT Plus to read the full story…